Novartis' Zolgensma Had Manipulated Data In Application, US FDA Says

 
• By Derrick Gingery
FDA entrance sign 2016
US FDA said it was told of the manipulated data after Zolgensma's approval, but that AveXis knew before clearance. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies